Researchers are turning to chemically reinforced peptides to attack cancer-driving proteins that conventional drugs cannot reach. By locking short protein fragments into rigid shapes through a process ...
Researchers at the University of Bath have developed a new technology that uses bacteria to build, chemically stabilize, and test millions of potential drug molecules inside living cells, making it ...
Researchers at the University of Bath have developed a new technology that uses bacteria to build, chemically stabilise, and test millions of potential drug molecules inside living cells, making it ...
Around 3 years ago, Dana-Farber Cancer Institute scientist Loren Walensky approached the venture firm Apple Tree Partners (ATP) with an idea. He and his team had found a way to use chemically stapled ...
Targeting the interaction between the C-terminal domain of the GluA2 subunit of AMPAR and brefeldin-resistant Arf-GEF 2 (BRAG2), a guanine nucleotide exchange factor for the small GTPase Arf6, ...
A team of researchers from the University of Utah and Sethera Therapeutics has uncovered a powerful new way to build more stable and drug-like peptides, opening the door to medicines that could target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results